TSS
TTNP

Two Sigma Securities’s Titan Pharmaceuticals TTNP Stock Holding History

Two Sigma Securities’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-985
Closed -$9.34K – 3601
2023
Q3 		$9.34K Buy
+985
New +$10.5K ﹤0.01% 2704
2020
Q1 		– Sell
-46
Closed -$5K – 2323
2019
Q4 		$5K Buy
+46
New +$5.54K ﹤0.01% 2285
2019
Q1 		– Sell
-3
Closed -$3K – 2449
2018
Q4 		$3K Buy
+3
New +$3.36K ﹤0.01% 2066
2018
Q1 		– Sell
-3
Closed -$16K – 2963
2017
Q4 		$16K Sell
3
-1
-25% -$6.22K ﹤0.01% 1645
2017
Q3 		$23K Buy
+4
New +$24.8K ﹤0.01% 820

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LFA
Level Financial Advisors East Amherst, New York $448M AUM 16.6% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Securities's TTNP Position: Q4 2023 in Review

Two Sigma Securities sold out of Titan Pharmaceuticals (TTNP) in Q4 2023, closing a stake of 985 shares — an estimated $9.34K sold.

Two Sigma Securities first reported a position in TTNP in Q3 2017 and held it in 5 quarters. The position peaked at $23K in Q3 2017. 16 funds tracked by Wall St. Rank hold TTNP as of Q4 2023.

  • Two Sigma Securities reported no remaining Titan Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 985 Titan Pharmaceuticals shares in Q4 2023, an estimated $9.34K.
  • Two Sigma Securities first reported a position in Titan Pharmaceuticals in Q3 2017 and held it in 5 quarters.
  • Two Sigma Securities's Titan Pharmaceuticals position peaked at $23K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.